Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in roche

Roche Studies Ocrevus, Experimental Drug In MS As Novartis Moves In

Roche has started a late-stage clinical trial for its molecule fenebrutinib and is doing a clinical trial of higher-dose Ocrevus against relapsing MS and primary progressive MS.

Read More

Roche Receives US Emergency Approval For Coronavirus Vs. Flu Test

With the approaching flu season, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be differentiated by symptoms alone.

Read More

Roche Bid To Retool Arthritis Drug For COVID-19 Fails

Pharmaceutical companies have been racing to develop treatments against the COVID-19 pandemic that has claimed nearly 660,000 lives and crippled economies.

Read More

Roche Maintains 2020 Outlook As Second-Quarter Sales Tumble On COVID-19 Hit

Second-quarter sales dropped 9.6% to 14.1 billion Swiss francs ($15.20 billion). Factoring out the strong Swiss franc, revenue fell 4%

Read More

EU Secures Potential COVID-19 Drugs From Roche, Germany's Merck

The medicine is also being tested on COVID-19 patients in combination with Gilead's antiviral remdesivir, the only drug so far authorised by the EU for use against COVID-19. Patients are still being recruited

Read More

EU Reaches Deals With Roche, Merck For Supply Of COVID-19 Drugs

The agreements follow requests from EU states in May to acquire the two drugs which are considered potentially useful against COVID-19.

Read More

Rising Swiss Rivalry As Roche And Novartis Target Same Diseases

Roche Chief Executive Severin Schwan is looking beyond cancer drugs to fresh treatment areas, while Novartis CEO Vas Narashiman bulks up in the same territory.

Read More

Roche Confirms 2020 Sales, Profit Outlook As Coronavirus Boosts Test Demand

Group sales in the first-quarter rose 7% to 15.1 billion Swiss francs ($15.57 billion), with drugs business revenue up 7% and diagnostics rising 5% at constant exchange rates.

Read More

Govt Issues Alert To Deter Use Of Roche's Avastin Drug For Eyes

Despite being a cancer drug, Avastin is often used by doctors globally for eye ailments even though it does not have US Food and Drug Administration approval for that purpose

Read More

Telangana, Gujarat Halt Sales Of Roche's Avastin

Fifteen patients lost their vision partially after using the company's cancer treatment drug in Ahmedabad

Read More

Drugmaker Shire Clinches Deal To Buy Baxalta For $32 Billion

The deal marks a strong start to mergers and acquisitions in healthcare in 2016 after the sector had its biggest deal-making streak in history last year, with global transactions totalling $673 billion

Read More